Johns Hopkins University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count).
Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.
Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.
Top-decile sponsor footprint
Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,448 total, page 5 of 29
Investigation on the Cortical Communication (CortiCom) System
NCT03567213
Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens
NCT05171478
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
NCT02871726
American Lung Association (ALA) Lung Health Cohort
NCT04543461
Cerebellar Stimulation for Aphasia Rehabilitation
NCT05093673
Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
NCT04797286
Physical Activity, Cardiac and Skeletal Muscle Energetics in Healthy Subjects and HFpEF Patients
NCT04998877
Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD
NCT04781972
Escitalopram and Language Intervention for Subacute Aphasia
NCT03843463
Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
NCT04601038
Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)
NCT04765137
CORE-COMPARE Pilot Study
NCT06170541
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
NCT04123314
Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH
NCT03845205
Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis
NCT03935295
Effects of Electrical Stimulation on Verbal Learning in Typical and Atypical Alzheimer's Disease
NCT04122001
Using Technology to Track Pain and Pain-related Outcomes
NCT04267588
Ketogenic Diet for New-Onset Absence Epilepsy
NCT04274179
Y of Central Maryland Head Start Asthma Implementation
NCT05004714
The Impact of COVID-19 on Maternal and Neonatal Outcomes
NCT05197621
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
NCT04164641
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
NCT04505618
Autologous Volar Fibroblast Injection Into the Stump Site of Amputees
NCT03947450
Critical Health Assessment and Outcomes Score/Study
NCT02766166
Patient Reported Outcomes for Vascular Malformations EmbolizatioN (PROVEN)
NCT04104464
Gravity Versus Vacuum Based Indwelling Tunneled Pleural Drainage System
NCT03831386
Skeletal Muscle Energetics and Fatiguability in Older Individuals
NCT04142047
Personalized Treatment in Thyroid Disorders
NCT03517579
Effects of Simvastatin on Uterine Leiomyoma Size
NCT03400826
Imaging Post-Stroke Recovery: Using MEG to Evaluate Cognition
NCT04188522
Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
NCT03150511
Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
NCT03803423
Bimatoprost as a Treatment for Graves' Orbitopathy
NCT03708627
Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin
NCT05066113
Investigation on the Bidirectional Cortical Neuroprosthetic System
NCT03161067
Human Upper Extremity Allotransplantation: F/U Protocol
NCT03400345
Exercise Intolerance in Heart Failure
NCT03775577
Achondroplasia Natural History Multicenter Clinical Study
NCT02597881
EsophaCap for the Detection of Early Esophageal Carcinoma
NCT04214119
Feasibility Study for Fibroblast Autologous Skin Grafts
NCT01964859
Human Penile Allotransplantation
NCT02395497
Influenza Immunization in Adults Over Age 75
NCT02200276
The Cancer of the Pancreas Screening-5 CAPS5)Study
NCT02000089
Human Craniomaxillofacial Allotransplantation
NCT01889381
Human Upper Extremity Allotransplantation
NCT01459107
Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk
NCT00181233
Left Ventricular Structural Predictors of Sudden Cardiac Death
NCT01076660
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
NCT00733590
Pancreatic Cancer Registry: For Any Person With a Personal or Family History
NCT02886247
Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism
NCT00181259
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 201 |
| Phase 2 | 198 |
| Phase 3 | 44 |
| Phase 4 | 81 |
Therapeutic Areas
What is open in the Johns Hopkins University pipeline
250 recruiting of 1,448 indexed (17% open); 943 completed (65%).
Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).
Top condition: Hypertension (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.